Ontology highlight
ABSTRACT: Background
Prognosis associated with metastatic renal cell carcinoma (mRCC) can vary widely.Methods
This study used pretreatment nephrectomy specimens from a randomized phase III trial. Expression levels of candidate genes were determined from archival tumors using the OpenArray® platform for TaqMan® RT-qPCR. The dataset was randomly divided at 2:1 ratio into training (n = 221) and testing (n = 103) sets to develop a multigene prognostic signature.Findings
Gene expressions were measured in 324 patients. In the training set, multiple models testing 424 candidate genes identified a prognostic signature containing 8 genes plus MSKCC clinical risk factors. In the testing set, the time dependent (td) AUC for a prognostic model containing the 8 genes with and without MSKC
SUBMITTER: Kim HL
PROVIDER: S-EPMC4740313 | biostudies-literature | 2015 Nov
REPOSITORIES: biostudies-literature